作为心血管风险标志物的ApoB,LDL-C和非HDL-C
Daniel Sehayek1, Justine Cole1, Elias Björnson2
1Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada (Drs Sehayek, Cole, Dufresne, K.M. Pencina, M.J. Pencina, Thanassoulis, and Sniderman).
Journal of clinical lipidology
|July 18, 2025
概括
阿波蛋白B (apoB) 是比LDL-C或非HDL-C更准确的心血管风险标志物.不一致性分析表明apoB应该是评估风险和指导降脂治疗的主要临床措施.
科学领域:
- 心脏病学 心脏病学
- 脂质代谢 脂质代谢是什么
- 生物标志物发现发现
背景情况:
- 传统的统计方法与高度相关的脂质变量 (如LDL-C,非HDL-C和apoB) 进行斗争.
- 不一致性分析是为了比较预测不同的标志物而开发的,解决了标准方法的局限性.
研究的目的:
- 系统地审查不一致性研究,将LDL-C和非HDL-C与LDL粒子数 (LDL P) 或apoB进行比较.
- 确定动脉样硬化心血管疾病风险的最准确标志物.
主要方法:
- 一个全面的PubMed搜索确定了15项研究,其中有593,354名参与者.
- 研究包括多种不同的人群,有和没有他类药物治疗.
- 采用了多种不同的不一致性分析方法 (中位数,百分位数,余数,基于差异的).
主要成果:
- 在9项研究中,9项研究中,ApoB的表现优于LDL-C.
- 在3个比较中,在2个比较中,LDL P优于LDL-C.
- 在7项研究中,ApoB的准确性明显高于非HDL-C.
结论:
- 与LDL-C和非HDL-C相比,不一致性分析证实apoB是一个优越的心血管风险标志物.
- LDL-C和非HDL-C是apoB的不充分的临床替代品.
- ApoB应该是评估脂蛋白风险和治疗有效性的首要临床措施.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
217
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
217
Coronary Artery Disease I: Introduction
59
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
59
Coronary Artery Disease IV: Preventive Measures
36
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
36
Atherosclerosis I: Introduction
89
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
89
Blood Studies for Cardiovascular System III: Serum Lipid Profile
296
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
296
Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36


